After being given a terminal diagnosis with only a few weeks to live, Jane dug up research, some decades old, in her quest to survive. Rather than aiming to cure cancer, which in many cases is unachievable, Jane\x27s approach was to stop it growing. Remarkably her approach not only stopped it growing, it disappeared altogether. There are now clinics following her protocol, achieving remarkable successes. This book is a game\-changing new dawn in the treatment of cancer. Jane McLelland McLelland was reluctant about writing her book, but she felt she had a duty to share with the world what she had discovered—and what had saved her life. Now doctors are starting to think more about specific nutrients that feed tumor cells. That is, how what we eat affects how cancers grow—and whether there are ways to potentially “starve” cancer cells without leaving a person undernourished, or even hungry.

Years later, she also discovered the anti-cancer effects of the antibiotic doxycycline (which slows the creation of new cancer cells) and of the anti-worming drug mebendazole (which stops the cancer cells from being able to take on more glucose).

Jane McLelland’s Key Cancer-Starving Supplements:

I already knew that statins would be potentially useful against cervical cancer. But research had also shown that they caused apoptosis in acute myeloid leukemias. I also had overlooked the fact that NSAIDs could cause cell death (apoptosis),” said McLelland. “What I learned from the Life Extension article was that there was a synergy between the two drugs, making them far more potent when taken together.” Unlike most cancer therapies, depleting arginine in the blood does not affect healthy cells. Normal cells don’t rely on external sources of arginine because they don’t have the cancer’s metabolic defect. They continue to make their own arginine, so there is no induced starvation in normal cells even when there is no arginine in the blood. Van Tine said this strategy is based on the properties of a tumor — it shuts down tumor metabolism specifically and nothing else. While the sugar-and-insulin angle has shown promise, more of the research has focused on dietary protein—or, specifically, individual amino acids that make up that protein. Studies have shown that the restriction of the amino acids serine and glycine can modulate cancer outcomes. According to a 2018 study in Nature, the chemotherapy drug methotrexate is affected by the amino acid histidine. Another, asparagine, is involved in the progression of breast cancer metastasis. We have determined that this metabolic defect is present in 90 percent of sarcomas,” said senior author Brian A. Van Tine, MD, PhD, an associate professor of medicine. “Healthy cells don’t have this weakness. We have been trying to create a therapy that takes advantage of the metabolic defect because, in theory, it should target only the tumor. Basically, the defect allows us to force the tumor cells to starve.” STARS! I'm in tears. I just finished chapter 19 of this book. I just love Jane! I love her. Her ❤️, her tenacity in the face of crazy levels of difficulty, and her desire to share!!

This book will answer all the burning questions you face when you begin to explore integrative treatments. Which ‘off-label’ drugs and supplements should you take? Should you try the ketogenic diet? Should you fast? Is fat safe? How much and when should you exercise? Jane explains why each patient needs a personalised approach and, importantly, how to work this out. One fan even asked for more updates regarding his lifestyle change and wrote: "Ooh could you post more of your meal pics? Very interested on how this works and what you eat, amazing. Keep on keeping on".

For your security, please follow the reCAPTCHA instructions below

That’s, uh, yeah,” he attempted to patiently explain. “It’s basically saying we can quantify what’s happening in the cells.” For now, unless an oncologist has advised a specific diet tailored to your specific tumor, the most common recommendation is to eat a generally healthy diet. None of this challenges the principle that staying well nourished is part of a healthy approach to any disease; and there is no evidence that overall starvation is good or even safe. But focusing on specific patterns of eating will likely be part of many cancer-treatment guidelines in coming years.

Last year, Siddhartha Mukherjee, the Columbia University researcher and author of The Emperor of All Maladies, and his colleagues found that at least one particular chemotherapy drug can be made more effective by combining its use with eating a low-sugar, protein-and-fat-heavy “ketogenic” diet. In a paper in Nature, the researchers suggest that the effect was related to decreasing the levels of insulin that the pancreas releases into the blood in response to eating.If you have any questions on the scientific content of this article, please call a Life Extension ® Wellness Specialist at 1-866-864-3027.

This work was supported by grants from CJ’s Journey; The Sarcoma Foundation of America; a Sarcoma Alliance for Research and Collaboration Career Development Award; and Polaris Pharmaceuticals. Polaris Pharmaceuticals provided funding and the arginine-depleting drug, ADI-PEG20 (pegylated arginine deiminase). What made the diagnosis even more tragic was the fact that McLelland’s doctor had misdiagnosed her for years. Since cervical cancer is highly treatable in its early stages, her tragedy could have been avoided.For people currently struggling with a cancer diagnosis, McLelland has an important message: Never give up. In her book, McLelland provides all the information a cancer patient might need to point them in the right direction for developing a protocol to starve their cancer. According to doctors and cancer statistics, she should have lived only about 12 weeks after receiving her diagnosis of stage IV cancer. In this truly ground-breaking book, Jane takes us through her remarkable, heart-breaking journey, and the medical discoveries she made along the way. The use of ‘off label’ drugs for treating cancer is finally gaining traction. Yet Jane discovered these herself in 2003. Unbeknown to her, she would become ‘patient zero’. Galima bandyti argumentuoti, kad čia tik vienas atvejis, kad nežinia dėl ko pavyko pasveikti, kad už pasveikimą atsakinga chemoterapija, o ne tie magiški vaistai. Visi šie punktai turi pagrindą. Tačiau lieka dar vienas didelis BET. Jane yra tokia gan konkreti ir ne iš kelmo spirta moteriškė, ir visą savo gydymo eigą, visus vaistus ir papildus ji kruopščiai research'ino. To rezultatas yra daugiau nei 250 nuorodų į atliktus tyrimus, ir rašydamas "tyrimus", aš turiu omeny tuos "tikrus" tyrimus, peer reviewed and published stiliaus tyrimus, kuriuos visus kiekvienas norintis gali susirasti tokiuose kuklučiuose saituose kaip NCBI, PubMed, International Journal of Oncology ir taip toliau.